Faculty, Staff and Student Publications

Publication Date

9-17-2024

Journal

Cell Reports Medicine

Abstract

Pancreatic cancer is associated with an oncogenic KRAS mutation in approximately 90% of cases. However, a non-negligible proportion of pancreatic cancer cases harbor wild-type KRAS (KRAS-WT). This study establishes genetically engineered mouse models that develop spontaneous pancreatic cancer in the context of KRAS-WT. The Trp53

Keywords

Smad4 Protein, Animals, Pancreatic Neoplasms, Tumor Suppressor Protein p53, Proto-Oncogene Proteins p21(ras), Mutation, Mice, Humans, Carcinoma, Adenosquamous, Disease Models, Animal, Receptor, Transforming Growth Factor-beta Type II, pancreatic ductal adenocarcinoma, pancreatic adenosquamous carcinoma, single-cell RNA-sequencing analysis, genetically engineered mouse models, tumor microenvironment

Comments

Associated Data

PMID: 39232498

fx1 (1).jpg (270 kB)
Graphical Abstract

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.